Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
17%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_2
8
89%
Ph phase_3
1
11%

Phase Distribution

0

Early Stage

8

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
8(88.9%)
Phase 3Large-scale testing
1(11.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(6)
Terminated(1)
Other(2)

Detailed Status

Completed6
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Phase 28 (88.9%)
Phase 31 (11.1%)

Trials by Status

terminated111%
unknown222%
completed667%

Recent Activity

Clinical Trials (9)

Showing 9 of 9 trials

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9